Enginprime Medical

Raised $12M in a Series A round, announced 18 August 2026.

Round

Enginprime Medical closed a $12 million Series A led exclusively by Qiming Venture Partners to fund clinical trials and global regulatory development of its ventricular assist platform.

Amount: $12M
Stage: Series A
Announced: 18 August 2026
Investors: Qiming Venture Partners
Checked: Announced by the company

Company

Develops percutaneous ventricular assist device technology for cardiac support

Based in: China
Sector: Health

Sources and links

Source: Enginprime Medical Closes $12M Series A Financing prnewswire.com

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost